Private Environmental Governance to Address Manufacturing Releases of Antibiotics
Demand for generic pharmaceuticals has resulted in China and India becoming the largest producers of these products in the world. Pollution from pharmaceutical manufacturing in both of these countries is a recognized environmental and public health problem, and the release of residual antibiotics is a contributor to antimicrobial resistance, which is projected to result in 10 million deaths per year by 2050 unless significant action is taken.